Hiroaki Nagata

1.9k total citations
35 papers, 1.6k citations indexed

About

Hiroaki Nagata is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Hiroaki Nagata has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Hiroaki Nagata's work include MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (5 papers). Hiroaki Nagata is often cited by papers focused on MicroRNA in disease regulation (8 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (5 papers). Hiroaki Nagata collaborates with scholars based in Japan and United States. Hiroaki Nagata's co-authors include Eigo Otsuji, Shuhei Komatsu, Daisuke Ichikawa, Atsushi Shiozaki, Hirotaka Konishi, Kazuma Okamoto, Tomohiro Arita, Shoji Hirajima, Tsutomu Kawaguchi and Hitoshi Fujiwara and has published in prestigious journals such as Blood, British Journal of Cancer and Applied Catalysis A General.

In The Last Decade

Hiroaki Nagata

28 papers receiving 1.5k citations

Peers

Hiroaki Nagata

ONCOL

SURGE

PRM

Jinxing Wei China

Huafang Su China

Lihao Zhao China

Zhenxiang Li China

Tong Lu China

Kunlin Xie China

Tianan Guo China

Kazuya Kawahara Japan

Xigan He China

Jinxing Wei China

Hiroaki Nagata

449 ×0.4

351 ×0.3

106 ×0.5

ONCOL

137 ×0.8

SURGE

137 ×1.2

PRM

Citations per year, relative to Hiroaki Nagata Hiroaki Nagata (= 1×) peers Jinxing Wei

Countries citing papers authored by Hiroaki Nagata

Since Specialization

Citations

This map shows the geographic impact of Hiroaki Nagata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Nagata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Nagata more than expected).

Fields of papers citing papers by Hiroaki Nagata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Nagata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Nagata. The network helps show where Hiroaki Nagata may publish in the future.

Co-authorship network of co-authors of Hiroaki Nagata

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Nagata. A scholar is included among the top collaborators of Hiroaki Nagata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Nagata. Hiroaki Nagata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsukamoto, Taku, Masakazu Nakano, Hiroaki Nagata, et al.. (2023). miR‐17‐92 cluster‐BTG2 axis regulates B‐cell receptor signaling in mantle cell lymphoma. Cancer Science. 115(2). 452–464. 3 indexed citations

Nagata, Hiroaki, Akio Onishi, Takahiro Fujino, et al.. (2022). Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature. Infection and Drug Resistance. Volume 15. 2723–2728. 1 indexed citations

Nagata, Hiroaki, et al.. (2019). [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].. PubMed. 59(4). 407–413.

Nagata, Hiroaki, Ken‐ichi Kozaki, Tomoki Muramatsu, et al.. (2017). Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Oncotarget. 8(23). 37740–37750. 21 indexed citations

Nagata, Hiroaki, et al.. (2016). Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes. World Journal of Clinical Oncology. 7(5). 380–380. 20 indexed citations

Arita, Tomohiro, Daisuke Ichikawa, Hirotaka Konishi, et al.. (2014). Increase in Peritoneal Recurrence Induced by Intraoperative Hemorrhage in Gastrectomy. Annals of Surgical Oncology. 22(3). 758–764. 31 indexed citations

Tsujiura, Masahiro, Shuhei Komatsu, Daisuke Ichikawa, et al.. (2014). Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer. 18(2). 271–279. 80 indexed citations

Hirajima, Shoji, Shuhei Komatsu, Daisuke Ichikawa, et al.. (2013). Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. British Journal of Cancer. 108(9). 1822–1829. 93 indexed citations

Komatsu, Shuhei, Daisuke Ichikawa, Masahiro Tsujiura, et al.. (2013). Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma.. PubMed. 33(1). 271–6. 83 indexed citations

10.

Kawaguchi, Tsutomu, Shuhei Komatsu, Daisuke Ichikawa, et al.. (2013). Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer. British Journal of Cancer. 108(2). 361–369. 188 indexed citations

11.

Nishimura, Yukihide, Shuhei Komatsu, Daisuke Ichikawa, et al.. (2013). Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. British Journal of Cancer. 108(6). 1324–1331. 98 indexed citations

12.

Konishi, Hirotaka, Daisuke Ichikawa, Shuhei Komatsu, et al.. (2012). Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. British Journal of Cancer. 106(4). 740–747. 171 indexed citations

13.

Komatsu, Shuhei, Daisuke Ichikawa, Tomohiro Arita, et al.. (2012). Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma. Cancer Science. 103(11). 2021–2026. 68 indexed citations

14.

Komatsu, Shuhei, Daisuke Ichikawa, Hiroki Takeshita, et al.. (2012). Prognostic impact of circulatingmiR-21andmiR-375in plasma of patients with esophageal squamous cell carcinoma. Expert Opinion on Biological Therapy. 12(sup1). S53–S59. 77 indexed citations

15.

Morimura, Ryo, Shuhei Komatsu, Daisuke Ichikawa, et al.. (2011). Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. British Journal of Cancer. 105(11). 1733–1740. 214 indexed citations

16.

Fukuda, Ken, et al.. (2008). Prognostic Factors in Patients with Colorectal Perforation. The Japanese Journal of Gastroenterological Surgery. 41(6). 605–611. 4 indexed citations

17.

Furutani, Akinobu, et al.. (2008). BOUVERET'S SYNDROME WITH SPONTANEOUSLY CLOSED BILIARY-ENTERIC FISTULA-A CASE REPORT-. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(5). 1186–1190. 2 indexed citations

18.

Furutani, Akinobu, et al.. (2008). INTESTINAL INTUSSUSCEPTION CAUSED BY AN INVERTED MECKEL'S DIVERTICULUM IN AN ADULT-A CASE REPORT-. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 69(10). 2561–2564. 1 indexed citations

19.

Nagata, Hiroaki. (1993). MECHANISM OF THROMBOCYTOPENIA IN DOGS INFECTED WITH BABESIA GIBSONI. Jūigaku kenkyū/Japanese journal of veterinary research. 41(1). 36–36. 1 indexed citations

20.

Matsui, Toshihiro, et al.. (1993). [A müllerian duct cyst treated by injection of minocycline: a case report].. PubMed. 39(1). 69–72. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact